Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...
5hon MSN
Zepbound maker Eli Lilly hits $1T market cap — becoming first drug company to reach milestone
Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...
Eli Lilly & Co. and Novo Nordisk A/S plan to start selling their popular obesity shots to employers through a new approach ...
Novo Nordisk cuts obesity drug prices to compete with Eli Lilly, offering new patient deals and nationwide access.
Mangoceuticals later clarified in a separate statement that while it "has no direct contractual relationship with Eli Lilly ...
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks? Investors will be watching what Trump makes happen.
The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy ...
The drugmaker said it has started selling higher doses of the injectable treatment for $349 a month to patients paying the ...
Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...
Novo Nordisk A/S faces intensifying GLP-1 competition, notably from Eli Lilly, prompting price cuts for Wegovy. Learn more ...
Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback